The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: Successes and lessons learned

Global Health Science and Practice

Volumn 4, Issue 1, 2016, Pages 87-98

  Shiferaw, Netsanet ^a   Salvador Davila, Graciela ^a   Kassahun, Konjit ^a   Brooks, Mohamad I ^a,b   Weldegebreal, Teklu ^c   Tilahun, Yewondwossen ^a   Zerihun, Habtamu ^a   Nigatu, Tariku ^a   Lulu, Kidest ^a   Ahmed, Ismael ^c   Blumenthal, Paul D ^d   Asnake, Mengistu ^a  

^a PATHFINDER INTERNATIONAL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; CRYOTHERAPY; ETHIOPIA; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HIV INFECTIONS; HUMAN; MASS SCREENING; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PHYSICAL EXAMINATION; PROCEDURES; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX;

CERVIX UTERI; CRYOTHERAPY; DELIVERY OF HEALTH CARE; ETHIOPIA; FEMALE; HEALTH FACILITIES; HIV INFECTIONS; HUMANS; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICAL EXAMINATION; UTERINE CERVICAL NEOPLASMS;

EID: 85011973726     PISSN: None     EISSN: 2169575X     Source Type: Journal    
DOI: 10.9745/GHSP-D-15-00325     Document Type: Article

References (26)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon (France): International Agency for Research on Cancer; 2013 [cited 2015 Jan 20]. Available from: Http://globocan.iarc.fr
2. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost. Int J Cancer. 2004;109(3): 418-424. CrossRef. Medline
3. Miller AB, editor. Epidemiologic studies in cancer prevention and screening. New York: Springer Science & Business Media; 2013.
4. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan S, Shanthakumari S, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: A cluster-randomised trial. Lancet. 2007;370(9585):398-406. CrossRef. Medline
5. Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S. Cervical cancer prevention: Safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007;196(4):407.e1-e8; discussion 407. e8-e9. CrossRef. Medline
6. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K; Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/ JHPIEGO Corporation Cervical Cancer Prevention Group [corrected]. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project. Lancet. 2003;361(9360):814-820. CrossRef. Medline
7. Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol. 2010;21(10):1935-1943. CrossRef. Medline
8. Kay M. Screening with acetic acid could prevent 22 000 deaths from cervical cancer in India every year. BMJ. 2013;346:f3935. CrossRef. Medline
9. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011;113(1):14-24. CrossRef. Medline
10. Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer. 2007;96(5): 738-743. CrossRef. Medline
11. Blumenthal PD, Lauterbach M, Sellors JW, Sankaranarayanan R. Training for cervical cancer prevention programs in low-resource settings: Focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet. 2005;(Suppl 2):S30-S37. CrossRef. Medline
12. Nene BM, Hiremath PS, Kane S, Fayette JM, Shastri SS, Sankaranarayanan R. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet. 2008;103(3): 232-236. CrossRef. Medline
13. Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Comparison of cervical cancer screening results among 256, 648 women in multiple clinical practices. Cancer Cytopathology. 2015;123(5): 282-288. CrossRef. Medline
14. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet. 2010;376(9747): 1186-1193. CrossRef. Medline
15. World Bank. World development indicators 2014. Washington (DC): World Bank; 2014. Available from: Http://data. worldbank.org/sites/default/files/wdi-2014-book.pdf
16. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva: UNAIDS; 2013. Available from: Http://www.unaids. org/sites/default/files/en/media/unaids/contentassets/ documents/epidemiology/2013/gr2013/ UNAIDS-Global-Report-2013-en.pdf
17. Alliance for Cervical Cancer Prevention (ACCP). Recent evidence on cervical cancer screening in low-resource settings. [Seattle (WA)]: ACCP; 2011. Available from: Http://screening.iarc.fr/ doc/ACCP-cxca-screening-2011.pdf
18. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008; 17(6):545-554. CrossRef. Medline
19. Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, et al. Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the women's interagency HIV study. J Acquir Immune Defic Syndr. 2001;27(5): 432-442. CrossRef. Medline
20. Stein L, Urban MI, O'Connell D, Yu XQ, Beral V, Newton R, et al. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: Results from a casecontrol study, 1995-2004. Int J Cancer. 2008;122(10): 2260-2265. CrossRef. Medline
21. World Health Organization (WHO). Comprehensive cervical cancer control: A guide to essential practice. 2nd ed. Geneva: WHO; 2014. Available from: Http://apps.who.int/iris/ bitstream/10665/144785/1/9789241548953-eng.pdf
22. Phongsavan K, Phengsavanh A, Wahlström R, Marions L. Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos. Int J Gynaecol Obstet. 2011;114(3):268-272. CrossRef. Medline
23. World Health Organization (WHO); International Agency for Research on Cancer; African Population and Health Research Center. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, & Zambia. Geneva: WHO; 2012. Available from: Http://apps.who.int/iris/bitstream/10665/75250/1/ 9789241503860-eng.pdf
24. Martin CE, Tergas AI, Wysong M, Reinsel M, Estep D, Varallo J. Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: Feasibility, effectiveness and lessons learned. J Obstet Gynaecol Res. 2014;40(6):1707-1716. CrossRef. Medline
25. Pathfinder International. Cervical cancer prevention among HIV positive women in the Federal Democratic Republic of Ethiopia: Final project report. Pathfinder International (Unpublished).
26. Kafuruki L, Rambau P, Massinde A, Masalu N. Prevalence and predictors of cervical intraepithelial neoplasia among HIV infected women at Bugando Medical Centre, Mwanza-Tanzania. Infect Agent Cancer. 2013;8(1):45. CrossRef. Medline